Table 1 X-ray crystallographic data collection and refinement statistics of FXN-nanobodies complexes

From: Nanobodies as tools for studying human frataxin biology

 

FXN:16C10

FXN:6B1

FXN:4A7

Data collection

Space group

P212121

P63 2 2

P212121

Cell dimensions

 a, b, c (Å)

57.90, 81.10, 107.55

97.25, 97.25, 128.11

38.52, 48.15, 111.43

 α, β, γ (°)

90, 90, 90

90, 90, 120

90, 90, 90

Wavelength

0.97926

0.97926

0.97926

Resolution (Å)

64.75–1.99 (2.18–1.99)a

84.22–1.48 (1.58–1.48)a

55.71–1.25 (1.33–1.25)a

Rsym or Rmerge

0.164

0.058

0.046

CC(1/2)

0.99 (0.39)

0.99 (0.57)

0.99 (0.60)

Mean I/σ (I)

14.2 (1.4)

33.5 (1.5)

23.6 (1.3)

Completeness (%)

91.7 (53.2)

96.8 (74.5)

89.3 (43.0)

Redundancy

11.5 (5.4)

38.4 (41.1)

10.7 (3.8)

Refinement

Resolution (Å)

64.75–2.00

50.98–1.48

55.71–1.50

No. reflections

25977

50812

34017

Rwork/Rfree

0.17/0.22

0.21/0.22

0.18/0.20

Molecules per a.u.

2

1

1

No. atoms

 Protein

1888

1935

1852

 Ligands

0

0

0

 Water

902

161

196

B-factors

28.8

25.6

18.2

Ramachandran

 

Favored/allowed (%)

96.67/2.71

98.00/2.00

98.71/0.86

 Disallowed (%)

0.62

0.41

0.43

R.m.s. deviations

 Bond lengths (Å)

0.007

0.006

0.006

 Bond angles (°)

0.996

0.799

0.845

PDB code

9HO6

9HO4

9HO5

  1. aValues in parentheses are for the highest-resolution shell. One crystal was used to solve the structure.